Coverage
-
October 29, 2019
Prothena investors urged a New York federal court Monday to grant their attorneys at Labaton Sucharow LLP and Levi & Korsinsky LLP $4.7 million in fees and give the final go-ahead to a $15.75 million deal with the biotechnology company, resolving securities fraud claims over a clinical trial.
2 other articles on this case.
View all »